Boston Partners Lowers Stock Position in Corteva, Inc. (NYSE:CTVA)

Boston Partners lowered its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 72.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 936,676 shares of the company's stock after selling 2,447,663 shares during the period. Boston Partners owned 0.14% of Corteva worth $53,399,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of CTVA. State Street Corp boosted its holdings in Corteva by 2.3% in the 3rd quarter. State Street Corp now owns 34,290,086 shares of the company's stock valued at $2,015,914,000 after purchasing an additional 768,519 shares during the period. Geode Capital Management LLC raised its position in shares of Corteva by 2.0% in the third quarter. Geode Capital Management LLC now owns 17,703,771 shares of the company's stock worth $1,037,505,000 after buying an additional 355,206 shares in the last quarter. Franklin Resources Inc. boosted its stake in Corteva by 6.1% during the third quarter. Franklin Resources Inc. now owns 14,788,607 shares of the company's stock valued at $860,746,000 after buying an additional 856,007 shares during the period. Harris Associates L P grew its position in Corteva by 1.4% during the third quarter. Harris Associates L P now owns 14,362,309 shares of the company's stock worth $844,360,000 after buying an additional 200,917 shares in the last quarter. Finally, FMR LLC increased its stake in Corteva by 1.9% in the 3rd quarter. FMR LLC now owns 10,747,791 shares of the company's stock worth $631,863,000 after acquiring an additional 203,126 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company's stock.

Remove Ads

Corteva Trading Up 0.7 %

Shares of Corteva stock traded up $0.40 on Monday, hitting $62.12. The stock had a trading volume of 2,117,827 shares, compared to its average volume of 3,045,524. The stock's 50-day simple moving average is $62.44 and its two-hundred day simple moving average is $59.90. Corteva, Inc. has a one year low of $50.01 and a one year high of $66.24. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. The stock has a market cap of $42.59 billion, a price-to-earnings ratio of 48.16, a PEG ratio of 1.68 and a beta of 0.79.

Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. As a group, sell-side analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were given a $0.17 dividend. The ex-dividend date was Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.09%. Corteva's dividend payout ratio is currently 52.71%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Barclays lifted their price target on Corteva from $62.00 to $64.00 and gave the company an "equal weight" rating in a research report on Tuesday, January 21st. Citigroup lifted their target price on shares of Corteva from $69.00 to $74.00 and gave the company a "buy" rating in a research report on Wednesday, January 29th. Oppenheimer increased their price target on shares of Corteva from $70.00 to $72.00 and gave the stock an "outperform" rating in a report on Friday, February 7th. Wells Fargo & Company lifted their price objective on shares of Corteva from $67.00 to $73.00 and gave the stock an "overweight" rating in a report on Tuesday, January 28th. Finally, Bank of America increased their target price on Corteva from $69.00 to $73.00 and gave the company a "buy" rating in a research note on Tuesday, February 11th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $68.00.

Insider Transactions at Corteva

In other news, insider Brian Titus sold 26,560 shares of the firm's stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the sale, the insider now directly owns 11,347 shares of the company's stock, valued at approximately $723,257.78. This trade represents a 70.07 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.14% of the company's stock.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.